New Clinical Data Shows BD Antigen Test May Be More Selective In Detecting Infectious COVID-19 Patients Than Molecular Tests
- Monday, January 25, 2021, 7:00
- Finance
- Add a comment
FRANKLIN LAKES, N.J., Jan. 25, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the publication of a peer-reviewed study that shows BD’s antigen test may be more selective than PCR (polymerase chain reaction)…
About the Author
adminasapcorp has written 41790 stories on this site.